The mRNA solution within the device plays a crucial role in the production of these personalized medicines. It carries the genetic instructions that guide the cells in producing the required protein to combat diseases. In the future, the use of mRNA could extend beyond the treatment of rare diseases.
NANOSPRESSO is funded by the Dutch Research Agenda (NWA) ORC 2020/21 program. For more information about our partners, funding, and legal notices, please visit our contact page and follow us on social media.